Advertisement
Canada markets close in 5 hours 28 minutes
  • S&P/TSX

    21,554.47
    -185.73 (-0.85%)
     
  • S&P 500

    5,048.09
    -13.73 (-0.27%)
     
  • DOW

    37,791.94
    +56.83 (+0.15%)
     
  • CAD/USD

    0.7227
    -0.0026 (-0.35%)
     
  • CRUDE OIL

    85.05
    -0.36 (-0.42%)
     
  • Bitcoin CAD

    86,502.27
    -4,048.77 (-4.47%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,383.90
    +0.90 (+0.04%)
     
  • RUSSELL 2000

    1,960.01
    -15.70 (-0.79%)
     
  • 10-Yr Bond

    4.6670
    +0.0390 (+0.84%)
     
  • NASDAQ

    15,857.68
    -27.34 (-0.17%)
     
  • VOLATILITY

    18.82
    -0.41 (-2.14%)
     
  • FTSE

    7,815.38
    -150.15 (-1.88%)
     
  • NIKKEI 225

    38,471.20
    -761.60 (-1.94%)
     
  • CAD/EUR

    0.6795
    -0.0029 (-0.43%)
     

Analyzing Nektar Therapeutics’ Operational Performance

Analyzing Nektar Therapeutics’ Operational Performance

Nektar Therapeutics’ (NKTR) cost of goods sold was $5.52 million in the second quarter of 2018 compared to $8.99 million in the second quarter of 2017.